Addressing the unmet needs of current antidepressants: does neuroscience help or hinder clinical psychopharmacology research?
Sign Up to like & getrecommendations! Published in 2017 at "Expert Opinion on Pharmacotherapy"
DOI: 10.1080/14656566.2017.1363178
Abstract: It is simple enough to enumerate the shortcomings of existing pharmacotherapies for depression: the desire for drugs with faster onsets, higher remission rates, fewer side effects, robust anti-suicide properties, breadth of spectrum across subtypes (melancholic,… read more here.
Keywords: current antidepressants; research; antidepressants neuroscience; unmet needs ... See more keywords